| Identification | Back Directory | [Name]
INDEX NAME NOT YET ASSIGNED | [CAS]
2408341-98-8 | [Synonyms]
PROTAC PTK6 ligand-1
(S)-3-((2S,4R)-4-Hydroxy-1-((R)-3-methyl-2-(3-methylisoxazol-5-yl)butanoyl)pyrrolidine-2-carboxamido)-3-(4-(4-methylthiazol-5-yl)phenyl)propanoic acid | [Molecular Formula]
C27H32N4O6S | [MOL File]
2408341-98-8.mol | [Molecular Weight]
540.63 |
| Chemical Properties | Back Directory | [Boiling point ]
827.5±65.0 °C(Predicted) | [density ]
1.334±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
4.12±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
PROTAC PTK6 ligand-1 is an intermediate for BTK kinase inhibitor preparation[1]. PROTAC PTK6 ligand-1 can be used in the synthesis of ARD-61 (HY-139659)[2]. | [References]
[1] Pyrrolo-aromatic heterocyclic compound, preparation method therefor, and medical use thereof. Patent WO2020010204. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|